Evidence map›Paper›PMID 34907702›Full record

ReviewJournal of applied biomedicine2019

Identification and applications of neuroactive silk proteins: a narrative review.

Ahad Banagozar Mohammadi, Saeed Sadigh-Eteghad, Mohammadali Torbati, Seyyed Mohammad Bagher Fazljou, Seyed Mehdi Vatandoust, Samad Ej Golzari, Fereshteh Farajdokht, Javad Mahmoudi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of applied biomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Evaluation and Comparison of the Effects of Mature Silkworm (Iranian journal of pharmaceutical research : IJPR · 2022
    Article
  7. Heliyon · 2022
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ahad Banagozar MohammadiTabriz University of Medical Sciences, Faculty of Traditional Medicine, Department of Traditional Medicine, Tabriz, Iran.
Saeed Sadigh-EteghadTabriz University of Medical Sciences, Neurosciences Research Center (NSRC), Tabriz, Iran.
Mohammadali TorbatiTabriz University of Medical Sciences, Faculty of Nutrition, Department of Food Science and Technology, Tabriz, Iran.
Seyyed Mohammad Bagher FazljouTabriz University of Medical Sciences, Faculty of Traditional Medicine, Department of Traditional Medicine, Tabriz, Iran.
Seyed Mehdi VatandoustTabriz University of Medical Sciences, Neurosciences Research Center (NSRC), Tabriz, Iran.
Samad Ej GolzariTabriz University of Medical Sciences, Research Center for Evidence Based Medicine, Tabriz, Iran.
Fereshteh FarajdokhtTabriz University of Medical Sciences, Neurosciences Research Center (NSRC), Tabriz, Iran.
Javad MahmoudiTabriz University of Medical Sciences, Neurosciences Research Center (NSRC), Tabriz, Iran.

Funding

Vice-Chancellor for Research of Tabriz University of Medical Sciences 59935
6 · The paper itself

Abstract

In traditional medicine, natural silk is regarded as a cognitive enhancer and a cure for ameliorating the symptoms of heart disease, atherosclerosis, and metabolic disorders. In this review, general characteristics of both silk proteins, fibroin and sericin, extracted from silkworm Bombyx mori and their potential use in the neuronal disorders was discussed. Evidence shows that silk proteins exhibit neuroprotective effects in models of neurotoxicity. The antioxidant, neuroprotective, and acetylcholinesterase inhibitory mechanisms of silk proteins could prove promising in the treatment of neurodegenerative diseases. Owing to their excellent neurocompatibility and physicochemical properties, silk proteins have been used as scaffolds and drug delivery materials in the neuronal tissue engineering. These data support the potential of silk proteins as an effective complementary agent for central and peripheral neurological disorders.

Indexed as

FibroinNeuroprotectionSericinSilk proteins

Identifiers

PMID34907702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.